2021 John N. Insall奖:阿司匹林可有效预防全膝关节置换术后膝下深静脉血栓进展
本研究回顾了5,078例全膝关节置换术后患者,其中532例(695膝,12.6%)在术后首次随访时经多普勒超声诊断为膝下深静脉血栓(IDVT)。91.4%(486/532)的患者接受阿司匹林325 mg每日两次治疗,4周后复查超声显示96.9%(445/459)的IDVT消退,仅2.2%(10/459)进展至腘静脉,无显著出血或伤口并发症。
要点
- 全膝关节置换术后IDVT发生率12.6%,阿司匹林治疗组IDVT消退率96.9%。
- 阿司匹林治疗组IDVT进展至腘静脉仅2.2%,肺栓塞1例。
- 阿司匹林治疗未增加出血、伤口并发症或其他不良事件。
核心结论
- 阿司匹林治疗全膝关节置换术后膝下深静脉血栓的进展率低,且未观察到显著出血、伤口相关并发症或其他不良事件。
研究设计与样本
- 单中心回顾性队列研究,纳入2014年1月1日至2019年12月31日期间5,078例全膝关节置换患者,其中532例(695膝,12.6%)经多普勒超声诊断IDVT。
主要发现
- 532例IDVT患者中91.4%(486/532)接受阿司匹林325 mg每日两次治疗并密切随访。
- 459/486(94.4%)患者完成4周后复查多普勒超声,其中445/459(96.9%)IDVT消退。
- 10/459(2.2%)患者IDVT进展至腘静脉,1例患者术后6周发生肺栓塞。
- 未观察到阿司匹林治疗相关的显著出血事件、伤口相关并发症或其他不良事件。
临床怎么用
- 对于全膝关节置换术后诊断为膝下深静脉血栓的患者,可考虑使用阿司匹林325 mg每日两次治疗,并密切随访症状及超声复查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The optimal management of an infrapopliteal deep venous thrombosis (IDVT) following total knee arthroplasty (TKA) remains unknown. The risk of DVT propagation and symptom progression must be balanced against potential haemorrhagic complications associated with administration of anticoagulation therapy. The current study reports on a cohort of patients diagnosed with IDVT following TKA who were treated with aspirin, followed closely for development of symptoms, and scanned with ultrasound to determine resolution of IDVT. METHODS: Among a cohort of 5,078 patients undergoing TKA, 532 patients (695 TKAs, 12.6%) developed an IDVT between 1 January 2014 to 31 December 2019 at a single institution, as diagnosed using Doppler ultrasound at the first postoperative visit. Of the entire cohort of 532 patients with IDVT, 91.4% (486/532) were treated with aspirin (325 mg twice daily) and followed closely. Repeat lower limb ultrasound was performed four weeks later to evaluate the status of IDVT. RESULTS: Follow-up Doppler ultrasound was performed on 459/486 (94.4%) patients and demonstrated resolution of IDVT in 445/459 cases (96.9%). Doppler diagnosed propagation of IDVT to the popliteal vein had occurred in 10/459 (2.2%) cases. One patient with an IDVT developed a pulmonary embolus six weeks postoperatively. CONCLUSION: The results of this study demonstrate a low rate of IDVT propagation in patients managed with aspirin. Additionally, no significant bleeding episodes, wound-related complications, or other adverse events were noted from aspirin therapy. Cite this article: Bone Joint J 2021;103-B(6 Supple A):18-22.
引用
- Omari AM, Parcells BW, Levine HB, et al. 2021 John N. Insall Award: Aspirin is effective in preventing propagation of infrapopliteal deep venous thrombosis following total knee arthroplasty. Bone Joint J. 2021. PMID: 34053277. doi:10.1302/0301-620X.103B6.BJJ-2020-2436.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。